A new UK-wide survey, conducted by Napp Pharmaceuticals, suggests that over half (54%, n=403) of GPs and nurses who treat patients with type 2 diabetes do not carry out a vital routine test annually, which is used to identify early markers of kidney damage.
Read More
Health Rss 